138 Episodes

  1. Ozanimod, a Selective Selective Sphingosine-1-Phosphatase Receptor Modulator, for Moderate-Severe Ulcerative Colitis: Re-Thinking the Top-Down Treatment Algorithm for UC

    Published: 12/13/2022
  2. Continuing Anti-TNF Agents past 24 Weeks of Pregnancy Associated with Fewer IBD Relapses with No Increase in Adverse Fetal Outcomes

    Published: 12/13/2022
  3. NSAID Use and the Risk of IBD Exacerbations: Fact or Fiction

    Published: 12/13/2022
  4. RBX2660, a Donor Stool Product for Fecal Microbiota Transplant, Decreases Recurrent Clostridioides difficile Infection: The First FDA-Approved Live Biotherapeutic Product

    Published: 12/13/2022
  5. ICYMI: Surgery is Superior to Medical Therapy for PPI-Refractory Heartburn in the “Right” Patients

    Published: 11/11/2022
  6. Vonoprazan, a Potassium-Channel Acid Blocker, is Superior to Lansoprazole for Managing Erosive Esophagitis

    Published: 11/11/2022
  7. Reinvestigating the Lack of Association Between Proton Pump Inhibitor Use and Mortality by Accounting for Reverse Causation

    Published: 11/11/2022
  8. Upadacitinib, a Selective JAK1 Inhibitor, for Moderate-Severe Ulcerative Colitis: Adjusting the Top-Down Treatment Algorithm for UC

    Published: 10/18/2022
  9. Acute pancreatitis: Need IV fluid resuscitation but avoid a WATERFALL!

    Published: 10/18/2022
  10. High Adenoma Detection Rate Decreases Post-Colonoscopy CRC in FIT-Based Screening Program: Quality Matters!

    Published: 10/18/2022
  11. Colonoscopy Reduces CRC Incidence and CRC-Related Mortality…. If You Get It!

    Published: 10/18/2022
  12. ICYMI-Pantoprazole Prophylaxis Does Not Reduce 90-day Mortality and Clinically Significant Adverse Events in ICU Patients

    Published: 9/21/2022
  13. Achieve IBD Remission Before Pregnancy: PIANO Registry Data Shows Adverse Perinatal Outcomes For Infants Associated with IBD Flares and Steroid Use; and Continue Thiopurines and Anti-TNF Agents If You

    Published: 9/21/2022
  14. Time to Increase Adenoma Detection Rate Benchmarks for Screening Colonoscopies

    Published: 9/21/2022
  15. ADR Isn’t the Only Game in Town: Proximal Serrated Lesion Detection Rates Predicts Interval Cancer Risk

    Published: 8/11/2022
  16. Tiny Polyps-It’s OK to Remove Polyps equal or less than 3mm with Large Biopsy Forceps

    Published: 8/11/2022
  17. Prophylactic Rifaximin Decreases Post-TIPS Hepatic Encephalopathy

    Published: 8/11/2022
  18. SER-109, an Oral Microbiome Therapy, Decreases Recurrent Clostridiodes difficile Infection

    Published: 6/16/2022
  19. When Is Routine Prophylactic Clipping Indicated Post-Polypectomy?

    Published: 6/9/2022
  20. Tenapanor (IBSRELA) for Treatment of IBS-C: Effective over 26 Weeks

    Published: 6/2/2022

6 / 7

A new monthly publication from the American College of Gastroenterology, Evidence-Based GI (EBGI) uses evidence-based methods to create abstracts and explain study results of new and important articles in the field of gastroenterology and hepatology. Listen as editors of EBGI discuss the articles they review and how the recommendations can be applied to your practice.